Ara
Toplam kayıt 6, listelenen: 1-6
Is the Probiotic Mixture Effective in the Treatment of TNBS-induced Experimental Colitis?
(Galenos Yayincilik, 2020)
Objective: Inflammatory bowel disease (IBD) is an idiopathic disease associated with changes in the immune system and in the intestinal microbiota. The most accepted hypothesis of IBD pathogenesis is thought to be the ...
Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome
(Aves, 2020)
Background/Aims: The objective of this study is to determine the role of circulating resolvin D1 (RvD1) in patients with constipation subtype of irritable bowel syndrome (IBS-C) and evaluate the relationship between abdominal ...
Immediate unprepared polyethylene glycol-flush colonoscopy in elderly patients with severe lower gastrointestinal bleeding
(WILEY, 2020)
Aims Colon preparation is vital yet more difficult in elderly patients with severe lower gastrointestinal bleeding (LGIB). The aim of this study is to show the efficacy, safety and outcomes of unprepared polyethylene glycol ...
TNBS ile Oluşturulmuş Deneysel Rat Kolit Modelinde Tedavide Karışım Probiyotikler Etkin midir?
(2020)
Amaç: Enflamatuvar barsak hastalıkları (EBH) kronik idiyopatik hastalıklardır. EBH patogenezinin en kabul edilen hipotezi, genetik, çevresel faktörler ve konakçı bağışıklık sistemi arasındaki karmaşık etkileşimlerin, anormal ...
The Role of Resolvin D1 in the Differential Diagnosis of the Cholangiocarcinoma and Benign Biliary Diseases
(CLIN LAB PUBL, 2020)
Background: The discrimination of malignant biliary strictures from benign biliary diseases (BBDs) is challenging and complicated. We aimed to investigate whether Resolvin D1 (RvD1) would aid in the discrimination of ...
The Performance of Nesfatin-1 in Distinguishing Irritable Bowel Syndrome Presenting Predominantly with Diarrhea from Celiac Disease
(CLIN LAB PUBL, 2020)
Background: We hypothesized that nesfatin-1, an anti-inflammatory peptide, could be used as a non-invasive diagnostic tool in the identification of celiac disease (CD) and irritable bowel syndrome presenting predominantly ...